Helicobacter pylori cag Pathogenicity Island (cagPAI) Involved in Bacterial Internalization and IL-8 Induced Responses via NOD1- and MyD88-Dependent Mechanisms in Human Biliary Epithelial Cells

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Boonyanugomol, Wongwarut ^a   Chomvarin, Chariya ^a   Hahnvajanawong, Chariya ^a   Sripa, Banchob ^a   Kaparakis Liaskos, Maria ^b   Ferrero, Richard L ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA5 BETA1 INTEGRIN ANTIBODY; ANTIBODY; BACTERIAL PROTEIN; CAGA PROTEIN; CAGL PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; BACTERIAL GENE; BACTERIAL INTERNALIZATION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BILE DUCT; BILE DUCT CARCINOMA; CELL ADHESION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; GENE EXPRESSION; HBD3 GENE; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTERNALIZATION; NOD1 GENE; NONHUMAN; PATHOGENICITY ISLAND; PROTEIN EXPRESSION; PROTEIN POLYMERIZATION; SIGNAL TRANSDUCTION; STOMACH CANCER; TLR2 GENE; TLR4 GENE; TLR5 GENE;

BACTERIAL ADHESION; BACTERIAL PROTEINS; BILIARY TRACT; CELL LINE, TUMOR; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GENOMIC ISLANDS; HELICOBACTER PYLORI; HUMANS; INTEGRIN ALPHA5BETA1; INTERLEUKIN-8; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; NOD1 SIGNALING ADAPTOR PROTEIN; TOLL-LIKE RECEPTORS;

EID: 84885455350     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077358     Document Type: Article

References (53)

1. Peek RM Jr, Blaser MJ, (2002) Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2: 28-37. doi:10.1038/nri700. PubMed: 11902583.
2. Huang Y, Fan XG, Wang ZM, Zhou JH, Tian XF, et al. (2004) Identification of Helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol 57: 1273-1277. doi:10.1136/jcp.2004.018556. PubMed: 15563667.
3. Leelawat K, Suksumek N, Leelawat S, Lek-Uthai U, (2007) Detection of VacA gene specific for Helicobactor pylori in hepatocellular carcinoma and cholangiocarcinoma specimens of Thai patients. Southeast Asian J Trop Med Public Health 38: 881-885. PubMed: 18041306.
4. Tiwari SK, Khan AA, Ibrahim M, Habeeb MA, Habibullah CM, (2006) Helicobacter pylori and other Helicobacter species DNA in human bile samples from patients with various hepato-biliary diseases. World J Gastroenterol 12: 2181-2186. PubMed: 16610018.
5. Sripa B, Kaewkes S, Sithithaworn P, Mairiang E, Laha T, et al. (2007) Liver fluke induces cholangiocarcinoma. PLOS Med 4: e201. doi:10.1371/journal.pmed.0040201. PubMed: 17622191.
6. Boonyanugomol W, Chomvarin C, Sripa B, Bhudhisawasdi V, Khuntikeo N, et al. (2012) Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation. HPB (Oxf) 14: 177-184. doi:10.1111/j.1477-2574.2011.00423.x. PubMed: 22321036.
7. Boonyanugomol W, Chomvarin C, Sripa B, Chau-In S, Pugkhem A, et al. (2012) Molecular analysis of Helicobacter pylori virulent-associated genes in hepatobiliary patients. HPB (Oxf) 14: 754-763. doi:10.1111/j.1477-2574.2012.00533.x. PubMed: 23043664.
8. Allison CC, Ferrero RL, (2010) Role of virulence factors and host cell signaling in the recognition of Helicobacter pylori and the generation of immune responses. Future Microbiol 5: 1233-1255. doi:10.2217/fmb.10.84. PubMed: 20722601.
9. Tegtmeyer N, Wessler S, Backert S, (2011) Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J 278: 1190-1202. doi:10.1111/j.1742-4658.2011.08035.x. PubMed: 21352489.
10. Kwok T, Zabler D, Urman S, Rohde M, Hartig R, et al. (2007) Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 449: 862-866. doi:10.1038/nature06187. PubMed: 17943123.
11. Hirata Y, Ohmae T, Shibata W, Maeda S, Ogura K, et al. (2006) MyD88 and TNF receptor-associated factor 6 are critical signal transducers in Helicobacter pylori-infected human epithelial cells. J Immunol 176: 3796-3803. PubMed: 16517750.
12. Boonyanugomol W, Chomvarin C, Baik SC, Song JY, Hahnvajanawong C, et al. (2011) Role of cagA-positive Helicobacter pylori on cell proliferation, apoptosis, and inflammation in biliary cells. Dig Dis Sci 56: 1682-1692. doi:10.1007/s10620-010-1512-y. PubMed: 21181444.
13. Boonyanugomol W, Chomvarin C, Song JY, Kim KM, Kim JM, et al. (2012) Effects of Helicobacter pylori gamma-Glutamyltranspeptidase on Apoptosis and Inflammation in Human Biliary Cells. Dig Dis Sci 57: 2615-2624. doi:10.1007/s10620-012-2216-2. PubMed: 22581342.
14. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, et al. (2004) Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5: 1166-1174. doi:10.1038/ni1131. PubMed: 15489856.
15. Gorrell RJ, Guan J, Xin Y, Tafreshi MA, Hutton ML, et al. (2012) A novel NOD1- and CagA-independent pathway of interleukin-8 induction mediated by the Helicobacter pylori type IV secretion system. Cell Microbiol.
16. Kaparakis M, Turnbull L, Carneiro L, Firth S, Coleman HA, et al. (2010) Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell Microbiol 12: 372-385. doi:10.1111/j.1462-5822.2009.01404.x. PubMed: 19888989.
17. Sripa B, Leungwattanawanit S, Nitta T, Wongkham C, Bhudhisawasdi V, et al. (2005) Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol 11: 3392-3397. PubMed: 15948244.
18. Tepsiri N, Chaturat L, Sripa B, Namwat W, Wongkham S, et al. (2005) Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. World J Gastroenterol 11: 2748-2753. PubMed: 15884115.
19. Hahnvajanawong C, Ketnimit S, Pattanapanyasat K, Anantachoke N, Sripa B, et al. (2012) Involvement of p53 and nuclear factor-kappaB signaling pathway for the induction of G1-phase cell cycle arrest of cholangiocarcinoma cell lines by isomorellin. Biol Pharm Bull 35: 1914-1925. PubMed: 22972485.
20. Namwat N, Amimanan P, Loilome W, Jearanaikoon P, Sripa B, et al. (2008) Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines. Chemotherapy 54: 343-351. doi:10.1159/000151541. PubMed: 18714155.
21. Grubman A, Kaparakis M, Viala J, Allison C, Badea L, et al. (2010) The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides. Cell Microbiol 12: 626-639. doi:10.1111/j.1462-5822.2009.01421.x. PubMed: 20039881.
22. Petersen AM, Blom J, Andersen LP, Krogfelt KA, (2000) Role of strain type, AGS cells and fetal calf serum in Helicobacter pylori adhesion and invasion assays. FEMS Immunol Med Microbiol 29: 59-67. doi:10.1111/j.1574-695X.2000.tb01506.x. PubMed: 10967262.
23. Hutton ML, Kaparakis-Liaskos M, Turner L, Cardona A, Kwok T, et al. (2010) Helicobacter pylori exploits cholesterol-rich microdomains for induction of NF-kappaB-dependent responses and peptidoglycan delivery in epithelial cells. Infect Immun 78: 4523-4531. doi:10.1128/IAI.00439-10. PubMed: 20713621.
24. Grassl GA, Bohn E, Müller Y, Bühler OT, Autenrieth IB, (2003) Interaction of Yersinia enterocolitica with epithelial cells: invasin beyond invasion. Int J Med Microbiol 293: 41-54. doi:10.1078/1438-4221-00243. PubMed: 12755365.
25. Ito K, Yamaoka Y, Ota H, El-Zimaity H, Graham DY, (2008) Adherence, internalization, and persistence of Helicobacter pylori in hepatocytes. Dig Dis Sci 53: 2541-2549. doi:10.1007/s10620-007-0164-z. PubMed: 18320323.
26. Watanabe T, Asano N, Kitani A, Fuss IJ, Chiba T, et al. (2010) NOD1-Mediated Mucosal Host Defense against Helicobacter pylori. Int J Inflam, 2010(2010): 476482. PubMed: 21152124.
27. Kawai T, Akira S, (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650. doi:10.1016/j.immuni.2011.05.006. PubMed: 21616434.
28. Pellicano R, Ménard A, Rizzetto M, Mégraud F, (2008) Helicobacter species and liver diseases: association or causation? Lancet Infect Dis 8: 254-260. doi:10.1016/S1473-3099(08)70066-5. PubMed: 18353266.
29. Petersen AM, Sørensen K, Blom J, Krogfelt KA, (2001) Reduced intracellular survival of Helicobacter pylori vacA mutants in comparison with their wild-types indicates the role of VacA in pathogenesis. FEMS Immunol Med Microbiol 30: 103-108. doi:10.1111/j.1574-695X.2001.tb01556.x. PubMed: 11267841.
30. Backert S, Selbach M, (2008) Role of type IV secretion in Helicobacter pylori pathogenesis. Cell Microbiol 10: 1573-1581. doi:10.1111/j.1462-5822.2008.01156.x. PubMed: 18410539.
31. Birkness KA, Gold BD, White EH, Bartlett JH, Quinn FD, (1996) In vitro models to study attachment and invasion of Helicobacter pylori. Ann N Y Acad Sci 797: 293-295. doi:10.1111/j.1749-6632.1996.tb52983.x. PubMed: 8993385.
32. Su B, Johansson S, Fällman M, Patarroyo M, Granström M, et al. (1999) Signal transduction-mediated adherence and entry of Helicobacter pylori into cultured cells. Gastroenterology 117: 595-604. doi:10.1016/S0016-5085(99)70452-X. PubMed: 10464135.
33. Mizejewski GJ, (1999) Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 222: 124-138. doi:10.1046/j.1525-1373.1999.d01-122.x. PubMed: 10564536.
34. Hynes RO, (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25. doi:10.1016/0092-8674(92)90115-S. PubMed: 1555235.
35. Allen LA, (1999) Intracellular niches for extracellular bacteria: lessons from Helicobacter pylori. J Leukoc Biol 66: 753-756. PubMed: 10577505.
36. Crabtree JE, Wyatt JI, Trejdosiewicz LK, Peichl P, Nichols PH, et al. (1994) Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol 47: 61-66. doi:10.1136/jcp.47.1.61. PubMed: 8132812.
37. Peek RM Jr, Miller GG, Tham KT, Perez-Perez GI, Zhao X, et al. (1995) Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 73: 760-770. PubMed: 8558837.
38. Glocker E, Lange C, Covacci A, Bereswill S, Kist M, et al. (1998) Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation. Infect Immun 66: 2346-2348. PubMed: 9573128.
39. Sharma SA, Tummuru MK, Blaser MJ, Kerr LD, (1998) Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol 160: 2401-2407. PubMed: 9498783.
40. Meyer-ter-Vehn T, Covacci A, Kist M, Pahl HL, (2000) Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem 275: 16064-16072. doi:10.1074/jbc.M000959200. PubMed: 10747974.
41. Backert S, Naumann M, (2010) What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol 18: 479-486. doi:10.1016/j.tim.2010.08.003. PubMed: 20863705.
42. Sharma SA, Tummuru MK, Miller GG, Blaser MJ, (1995) Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun 63: 1681-1687. PubMed: 7729872.
43. Crabtree JE, Xiang Z, Lindley IJ, Tompkins DS, Rappuoli R, et al. (1995) Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol 48: 967-969. doi:10.1136/jcp.48.10.967. PubMed: 8537502.
44. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, et al. (1996) cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 93: 14648-14653. doi:10.1073/pnas.93.25.14648. PubMed: 8962108.
45. Yamaoka Y, Kudo T, Lu H, Casola A, Brasier AR, et al. (2004) Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology 126: 1030-1043. doi:10.1053/j.gastro.2003.12.048. PubMed: 15057743.
46. Shaffer CL, Gaddy JA, Loh JT, Johnson EM, Hill S, et al. (2011) Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteria-host cell interface. PLOS Pathog 7: e1002237. PubMed: 21909278.
47. Cho SO, Kim KH, Yoon JH, Kim H, (2006) Signaling for integrin alpha5/beta1 expression in Helicobacter pylori-infected gastric epithelial AGS cells. Ann N Y Acad Sci 1090: 298-304. doi:10.1196/annals.1378.032. PubMed: 17384273.
48. Zhang Y, Fan XG, Chen R, Xiao ZQ, Feng XP, et al. (2005) Comparative proteome analysis of untreated and Helicobacter pylori-treated HepG2. World J Gastroenterol 11: 3485-3489. PubMed: 15948260.
49. da Silva Correia J, Miranda Y, Leonard N, Hsu J, Ulevitch RJ, (2007) Regulation of Nod1-mediated signaling pathways. Cell Death Differ 14: 830-839. doi:10.1038/sj.cdd.4402070. PubMed: 17186025.
50. Kawahara T, Teshima S, Oka A, Sugiyama T, Kishi K, et al. (2001) Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun 69: 4382-4389. doi:10.1128/IAI.69.7.4382-4389.2001. PubMed: 11401977.
51. Smith MF Jr, Mitchell A, Li G, Ding S, Fitzmaurice AM, et al. (2003) Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 278: 32552-32560. doi:10.1074/jbc.M305536200. PubMed: 12807870.
52. Su B, Ceponis PJ, Lebel S, Huynh H, Sherman PM, (2003) Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect Immun 71: 3496-3502. doi:10.1128/IAI.71.6.3496-3502.2003. PubMed: 12761134.
53. Naiki Y, Michelsen KS, Zhang W, Chen S, Doherty TM, et al. (2005) Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. J Biol Chem 280: 5491-5495. PubMed: 15623538.